Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Nasus Pharma Ltd. (NSRX) had Operating Cash Flow per Share of $-0.61 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-5.86M |
|
-- |
|
-- |
|
$4.90M |
|
$-4.90M |
|
$-0.90M |
|
$-5.80M |
|
$-5.80M |
|
$-5.80M |
|
$-5.80M |
|
$-5.86M |
|
$-5.80M |
|
$-4.90M |
|
$-4.90M |
|
8.01M |
|
8.01M |
|
$-0.72 |
|
$-0.72 |
|
| Balance Sheet Financials | |
$4.86M |
|
$0.01M |
|
$0.15M |
|
$5.00M |
|
$2.16M |
|
-- |
|
$0.07M |
|
$2.24M |
|
$2.77M |
|
$2.77M |
|
$2.77M |
|
9.02M |
|
| Cash Flow Statement Financials | |
$-4.92M |
|
$-3.01M |
|
$8.92M |
|
$0.31M |
|
$1.29M |
|
$0.98M |
|
$0.45M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.24 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.93M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-209.72% |
|
-209.72% |
|
-116.01% |
|
-209.72% |
|
$0.31 |
|
$-0.62 |
|
|
Operating Cash Flow per Share |
$-0.61 |